Doyle John B, Sethi Amrita
Division of Digestive and Liver Diseases, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, NY 10032, USA.
J Clin Med. 2023 Apr 6;12(7):2736. doi: 10.3390/jcm12072736.
Endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic biliary drainage (PTBD) are currently first- and second-line therapeutic options, respectively, for the relief of biliary obstruction. In recent years, however, endoscopic ultrasound-guided biliary drainage (EUS-BD) has become an established alternative therapy for biliary obstruction. There are multiple different techniques for EUS-BD, which can be distinguished based on the access point within the biliary tree (intrahepatic versus extrahepatic) and the location of stent placement (transenteric versus transpapillary). The clinical and technical success rates of biliary drainage for EUS-BD are similar to both ERCP and PTBD, and complication rates are favorable for EUS-BD relative to PTBD. As EUS-BD becomes more widely practiced and endoscopic tools continue to advance, the outcomes will likely improve, and the breadth of indications for EUS-BD will continue to expand.
内镜逆行胰胆管造影术(ERCP)和经皮经肝胆道引流术(PTBD)目前分别是缓解胆道梗阻的一线和二线治疗选择。然而,近年来,内镜超声引导下胆道引流术(EUS-BD)已成为一种既定的胆道梗阻替代治疗方法。EUS-BD有多种不同技术,可根据胆管树内的接入点(肝内与肝外)和支架置入位置(经肠与经乳头)进行区分。EUS-BD胆道引流的临床成功率和技术成功率与ERCP和PTBD相似,相对于PTBD,EUS-BD的并发症发生率较低。随着EUS-BD的应用越来越广泛,内镜工具不断进步,其治疗效果可能会改善,EUS-BD的适应证范围也将继续扩大。